2009 East Asia Hemophilia Forum Secretariat

c/o Congress Corporation
5-1 Kojimachi, Chiyoda-ku
Tokyo 102-8481 Japan
Tel: +81-3-5216-5551
Fax: +81-3-5216-5552
e-mail: eahf2009@congre.co.jp

Scheduled Program(Updated version)

6th June, 2009

Conference venue: Kitakyushu International Conference Center, International Conference Room

17:45-17:50

Opening Remarks

Akira Yoshioka (Honorary Chairman)

17:50-19:10

Symposium I

Chairpersons  Hideyuki Takedani, Myung Chul Yoo

Arthroscopic Synovectomy Combined with Reduced Weight-bearing Using a Patella Tendon-bearing Brace for Progressed Haemophilic Ankle Arthropathy in Paediatric Patients

Yusuke Inagaki (Nara Medical University, Japan)

Total Knee Arthroplasty for Severe Hemophilic Arthropathy: The Long-term Experience in Taiwan

Po-Quang Chen (National Taiwan University Hospital, Taiwan)

Does Hemophilia Adversary Affect the Outcome of Cementless Total Hip Arthroplasty THA?

Myung Chul Yoo (Kyung Hee University, Korea)

MRI Assessment of Hemophilic Arthropathy of Japanese children

Hisaya Nakadate (Kitasato University Hospital, Japan)

19:30-21:00 Welcome Reception (Rihga Royal Hotel, Kokura)

7th June, 2009

Conference venue: Kitakyushu International Conference Center, International Conference Room

7:30-8:30 Business Meeting
9:30-11:10

Symposium II

Chairpersons  Jun Mimuro, Keiko Shinozawa

The World Federation of Hemophilia: Achieving Treatment for All

Robert Leung (World Federation of Hemophilia)

Development of Immune Tolerance Induction by Intrathymic Administration of Factor VIII in Murine Hemophilia A

Seiji Madoiwa (Jichi Medical University, Japan)

The Prevalence and Genetic Background of Factor VIII Inhibitors in Chinese Hemophilia A Patients

Xuefeng Wang (Ruijin Hospital, China)

KoHemGene: A System Database for Hemophilia Registry Innovating the Process from Benchwork to Clinic Through Bioinformatics

Hee Jin Kim (Sungkyunkwan University School of Medicine, Korea)

A Study of Fifty Non-hemophilic Patients with Factor VIII Inhibitors in Taiwan - Level of LDH Can Predict the Response to Immunosuppressive Therapy

Ming-Ching Shen (Changhua Christian Hospital, Taiwan)

11:10-11:30 Break
11:30-12:20

Luncheon Session co-sponsored by Novo Nordisk Pharma Ltd.

Chairperson  Midori Shima

Current and Future Aspect for Monitoring Haemostatic Intervention in Patients with Haemophilia

Benny Sørensen (St Thomas' Hospital, UK)

12:20-12:30 Break
12:30-13:50

Symposium III

Chairpersons  Ming Ching Shen, Tai Ju Hwang

Characteristics of Joint Arthropathy and Gait Pattern in Hemophilia Patient

Ta-Sen Wei (Changhua Christian Hospital, Taiwan)

A Clinical Significance of Helicobacter Pylori Infection in Hemophilic Children with Gastrointestinal Bleeding

Ji Yoon Kim (Chungbuk National University Hospital, Korea)

Higher Response Rate from Peginterferon Alfa 2a Plus Ribavirin in Chronic Hepatitis C Patients with Hemophilia

Ki Young Yoo (Korea Hemophilia Foundation Clinic, Korea)

von Willebrand Disease in Taiwan: A Clinical and Laboratory Study of 61 Patients

Yeu-Chin Chen (Tri-Service General Hospital, Taiwan)

13:50-13:55 Break
13:55-14:55

Special Lecture

Chairperson  Yong Mook Choi

Hepatocyte Engineering and Tissue Engineering for Hemophilia

Kazuo Ohashi (Tokyo Women's Medical University, Japan)

14:55-15:00

Closing Remarks

Akira Shirahata (President of the 32nd Congress of JSTH)